Assertio Holdings Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| AZN | AstraZeneca PLC | Outperform |
17
|
£121.10 | Buy/Sell | £165.99 | 34.64% | 16 | £187.73B |
| AMGN | Amgen | Outperform |
4
|
$312.47 | Buy/Sell | $303.65 | 2.41% | 8 | $167.62B |
| PFE | Pfizer | Outperform |
2
|
$28.64 | Buy/Sell | $32.87 | 6.49% | 6 | $162.29B |
| GILD | Gilead Sciences Inc | Outperform |
11
|
$67.72 | Buy/Sell | $87.82 | 18.13% | 14 | $84.36B |
| 4568 | Daiichi Sankyo Company | Buy |
4
|
¥5.53k | Buy/Sell | ¥5.24k | 7.58% | 0 | ¥10.60T |
| 4502 | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.13k | Buy/Sell | ¥4.74k | 8.96% | 0 | ¥6.48T |
| JAZZ | Jazz Pharmaceuticals | Outperform |
14
|
$108.99 | Buy/Sell | $188.32 | 72.49% | 4 | $7.13B |
| HLUN A | H. Lundbeck A/S | Outperform |
18
|
kr37.40 | Buy/Sell | kr190.00 | 4.28% | 6 | kr36.60B |
| INSM | Insmed | Buy |
11
|
$24.77 | Buy/Sell | $41.42 | 77.63% | 8 | $3.92B |
| PBH | Prestige Consumer Healthcare | Outperform |
16
|
$64.65 | Buy/Sell | $71.50 | 13.69% | 3 | $3.55B |
| BHC | Bausch Health Companies | Hold |
15
|
$6.77 | Buy/Sell | $9.50 | 40.32% | 5 | $2.55B |
| AMPH | Amphastar Pharmaceuticals | Outperform |
14
|
$43.48 | Buy/Sell | $69.00 | 42.59% | 0 | $2.09B |
| SUPN | Supernus Pharmaceuticals | Outperform |
16
|
$29.10 | Buy/Sell | $41.00 | 40.89% | 0 | $1.72B |
| ANIP | ANI Pharmaceuticals | Buy |
13
|
$61.43 | Buy/Sell | $69.75 | 30.23% | 1 | $1.38B |
| IRWD | Ironwood Pharmaceuticals | Buy |
14
|
$6.48 | Buy/Sell | $17.83 | 139.20% | 2 | $1.29B |
| COPN | Cosmo Pharmaceuticals N.V. | Buy |
12
|
CHF72.90 | Buy/Sell | CHF76.55 | 28.34% | 0 | CHF1.14B |
| COLL | Collegium Pharmaceutical | Outperform |
11
|
$32.47 | Buy/Sell | $37.75 | 23.19% | 1 | $1.24B |
| PCRX | Pacira BioSciences | Outperform |
16
|
$30.82 | Buy/Sell | $47.90 | 42.76% | 6 | $1.23B |
| AQST | Aquestive Therapeutics | Buy |
0
|
$3.11 | Buy/Sell | $6.33 | 189.39% | 0 | $307.71M |
| NKTR | Nektar Therapeutics | Hold |
11
|
$1.76 | Buy/Sell | $2.75 | -9.09% | 2 | $301.14M |
| CHRS | Coherus BioSciences | Outperform |
6
|
$2.12 | Buy/Sell | $10.86 | 277.36% | 3 | $255.37M |
| EBS | Emergent BioSolutions | Outperform |
16
|
$5.55 | Buy/Sell | $5.00 | -9.91% | 0 | $229.00M |
| ABEO | Abeona Therapeutics | Buy |
8
|
$4.40 | Buy/Sell | $21.25 | 286.36% | 2 | $114.89M |
| DRRX | DURECT | Outperform |
9
|
$0.93 | Buy/Sell | $6.75 | 813.98% | 2 | $33.21M |
| ALVIO | Valerio Therapeutics Société... | - |
8
|
0.13€ | Buy/Sell | 1.30€ | 15.38% | 0 | 26.19€M |
| ENZN | Enzon Pharmaceuticals | - |
0
|
$0.09 | Buy/Sell | $16.00 | -100.00% | 0 | $8.48M |
| ACOR | Acorda Therapeutics | - |
5
|
$0.43 | Buy/Sell | $200.00 | -100.00% | 1 | $0.53M |
| DMK | DMK Pharmaceuticals | - |
8
|
$0.03 | Buy/Sell | $1.50 | -100.00% | 0 | $0.35M |